|
Start Date:Tuesday 13 April 2021
Start Time:6:00 CST (USA) / 07:00 ET (USA) / 12:00 BST (UK) / 13:00 CEST (Europe) / 19:00 CST (China)
Duration:90 minutes
Abstract:
Chaired by Professor Meg Jardine (University of Sydney, Australia), this webinar will examine potassium homeostasis in CKD and the epidemiology of hyperkalemia in CKD and ESKD. It will cover emerging evidence for novel approaches to potassium management, including low-potassium diets and novel K+ binders, and strategies to optimize RAASi therapy in patients with hyperkalemia. The webinar will also review the recent KDIGO guidance updates for hyperkalemia management followed by an interactive panel discussion.
If you're already registered for the Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies webcast, click below:
ALREADY REGISTERED?
Speakers
 Anonymized 47781918
 Anonymized 47781941
 Anonymized 47781967
 Anonymized 47781980
 Anonymized 47782008
|
Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies
Registration Is Closed
|
|
|
|